The Medical Science Liaison (MSL) role continues to evolve—no longer just a scientific resource, but a strategic partner, a listener, and often, a subtle agent of change. While data remains at the core of what we do, it’s how we deliver that data—and more importantly, how we connect with healthcare professionals (HCPs)—that separates a good MSL from a truly impactful … [Read more...]

Medical Science Liaisons (MSLs) serve as pivotal links between healthcare companies (i.e., pharma, biotech, medical device, etc.) and Key Opinion Leaders (KOLs), translating scientific conversations into strategic insights. Gathering actionable insights from KOLs has increasingly become a critical activity for MSLs, with many companies measuring the success of their MSL teams … [Read more...]

The 2024 MSL of the Year Awards, held during the 12th Annual MSL Society Conference in Miami (September 3-5, 2024), celebrated excellence in field Medical Affairs on a global scale. The awards are open to all MSLs and MSL Managers worldwide and recognize outstanding contributions across eight categories, including MSL of the Year, MSL Rookie of the Year, and MSL Manager of the … [Read more...]

Introduction Any career advice you give or receive is sure to include a conversation on the importance of networking. For many, especially early on in your career, this can seem intimidating, but there is a reason everyone always encourages expanding your network. The values that networking can bring are endless. This may be a connection that helps you land your next job, … [Read more...]

The transition from being part of a commercial team working in the sales-related function to the role of Medical Science Liaison (MSL) does not come without challenges. In the Middle East region, such a shift in careers is increasingly common in both local and international pharmaceutical companies. An educational background in pharmacy, science, and medicine is standard to … [Read more...]

The Medical Science Liaison (MSL) role has become crucial in pharmaceutical companies, bridging scientific research and clinical practice. Landing a first role as an MSL is not always easy, as many job postings require prior experience in the position. Pursuing specialized training focused on the MSL role and Medical Affairs can be a way to enhance one’s CV and make it more … [Read more...]

How clear, positive communications can steer the product’s narrative journey to success Introduction It is the moment of truth. Launch is that critical time when the science, clinical need, regulation, and reimbursement coalesce with elegant symmetry or smash together like atoms colliding. If Proof of Concept is a product’s birth then launch excellence is its coming of … [Read more...]

In the complex landscape of biotechnology, pharma, and medical devices, medical affairs teams serve as the critical bridge between clinical science and healthcare practitioners. The application of servant leadership principles in this space has emerged as a powerful approach to enhance both team performance and team satisfaction. By putting the needs of team members first, … [Read more...]

Why Traditional Advisory Boards No Longer Work Medical affairs teams and MSLs often rely on advisory boards to gain insights from clinicians and KOLs. But let’s be honest—most traditional advisory boards are too long, too formal, and too inefficient. Clinicians arrive at a meeting, only to see an agenda and a set of predetermined questions for the first time. The … [Read more...]

With highly regarded field medical relationships, there is an opportunity for improvement A recent Veeva industry report shows that 86% of key opinion leaders (KOLs) are satisfied overall (74% satisfied, 12% very satisfied) when engaging with the biopharma industry. They appreciate their interactions with field medical teams and cite alignment and coordination across … [Read more...]

Introduction and objectives The Medical Science Liaison (MSL) role has emerged as a sought-after career path in the pharmaceutical industry, attracting professionals from diverse backgrounds who seek continuous learning and aspire to contribute actively to scientific and medical progress. The MSL role is a profession with a significant impact on the pharmaceutical … [Read more...]

Background Medical affairs organizations have historically relied on various methods to assess payer sentiment toward clinical evidence and health economic value. These methods include advisory boards, surveys, and market research, each of which has inherent limitations. While they provide valuable insights, these approaches are often time-consuming and resource-intensive … [Read more...]

Medical Science Liaisons (MSLs) are vital in advancing medical strategy through scientific engagement and insight generation. Due to the unique nature of their role, traditional MSL performance metrics often fall short, failing to capture the full impact of individual or team contributions to Medical Affairs department goals. This article explores how artificial intelligence … [Read more...]

Field-based medical (FBM) teams act as a scientific bridge between the pharmaceutical/biotech company and healthcare providers (HCPs). Their work is non-promotional and aims to improve patient care by acting as a trusted partner and liaison. Traditionally, the performance of FBM teams has been assessed using quantitative metrics like reach and frequency. That is, how many HCPs … [Read more...]

Disclosure: This text represents my own views and not the ones of my former or current employer(s). The Medical Science Liaison (MSL) is expected to bond with the HCPs and have long-standing relationships which can be the root of a strategic performance. Thus, the MSL can be regarded as the “CEO” of the attributed territory. As CEOs plan to have an impact on the customers … [Read more...]

Strategies for optimizing every HCP interaction How do you ensure every minute you get with a Healthcare Provider optimizes the value of the interaction, for both you and the Provider? Gaining access to every HCP is becoming more challenging. When you do finally gain access, the time you have keeps shrinking, along with how frequently you can see that HCP. So, how do you … [Read more...]

It is common to hear this comment from the organizers in any virtual session. This is a negative tactic because delaying the start of a meeting has a negative impact on the time dedicated to business activities, rewards tardiness, and penalizes punctuality. Here's why we should begin promptly: **Time is valuable**: If 50 colleagues wait 3 minutes in a session, we lose 150 … [Read more...]